Cargando…
A Prediction Model of Pretreatment HIV RNA Levels in Naïve Thai HIV-infected Patients: An Application for Resource-limited Settings
BACKGROUND: The use of abacavir (ABC) and rilpivirine (RPV) in the first-line regimen for naïve HIV-infected patients with pretreatment HIV RNA >100,000 copies/mL is not recommended due to a high rate of treatment failure. If a model could accurately predict pretreatment HIV RNA levels, it would...
Autores principales: | Pongpech, Nisha, Avihingsanon, Anchalee, Chaiwarith, Romanee, Kantipong, Pacharee, Boettiger, David, Ross, Jeremy, Kiertiburanakul, Sasisopin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630810/ http://dx.doi.org/10.1093/ofid/ofx163.1097 |
Ejemplares similares
-
Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis
por: Boettiger, David C., et al.
Publicado: (2021) -
The treatment outcomes of antiretroviral substitutions in routine clinical settings in Asia; data from the TREAT Asia HIV Observational Database (TAHOD)
por: Jung, In Young, et al.
Publicado: (2017) -
Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings
por: Kiertiburanakul, Sasisopin, et al.
Publicado: (2017) -
Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost‐effectiveness analysis
por: Boettiger, David C, et al.
Publicado: (2020) -
The Safety of Substitution of Antiretroviral Regimen in Non-Clinical Trial Settings in Asian Countries
por: Jung, In Young, et al.
Publicado: (2017)